What is Celldex Therapeutics, Inc's Market Cap?

Celldex Therapeutics, Inc's Market Cap is $3.1B, based on as-reported figures from SEC (XBRL) filings.

What is Celldex Therapeutics, Inc's Enterprise Value?

Celldex Therapeutics, Inc's Enterprise Value is $2.4B, based on as-reported figures from SEC (XBRL) filings.

What is Celldex Therapeutics, Inc's Price / Sales?

Celldex Therapeutics, Inc's Price / Sales is 19443.5×, based on as-reported figures from SEC (XBRL) filings.

What is Celldex Therapeutics, Inc's EV / Revenue?

Celldex Therapeutics, Inc's EV / Revenue is 14901.8×, based on as-reported figures from SEC (XBRL) filings.

What is Celldex Therapeutics, Inc's EV / EBITDA?

Celldex Therapeutics, Inc's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Celldex Therapeutics, Inc's Revenue (TTM)?

Celldex Therapeutics, Inc's Revenue (TTM) is $158.0K, based on as-reported figures from SEC (XBRL) filings.

What is Celldex Therapeutics, Inc's Net Income (TTM)?

Celldex Therapeutics, Inc's Net Income (TTM) is -$300.5M, based on as-reported figures from SEC (XBRL) filings.

What is Celldex Therapeutics, Inc's EBITDA?

Celldex Therapeutics, Inc's EBITDA is -$322.4M, based on as-reported figures from SEC (XBRL) filings.

What is Celldex Therapeutics, Inc's Diluted EPS (TTM)?

Celldex Therapeutics, Inc's Diluted EPS (TTM) is -3.83, based on as-reported figures from SEC (XBRL) filings.

What is Celldex Therapeutics, Inc's EBITDA Margin?

Celldex Therapeutics, Inc's EBITDA Margin is -204070.9%, based on as-reported figures from SEC (XBRL) filings.

Celldex Therapeutics, Inc (CLDX) Financial Statements

Celldex Therapeutics, Inc

SIC 2835 · IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES

FIGI BBG001S7QN20

XNAS · usd

39.12▼ 0.56 (-1.41%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close39.68

Day's Range38.50 – 39.87

52-Week Range22.10 – 45.14

Volume833.5K

Avg Volume800.4K

Share Statistics

Shares Outstanding

Employees198

ExchangeXNAS

Listed1986-05-15

Share count as of July 29, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Celldex Therapeutics, Inc (CLDX)

What is Celldex Therapeutics, Inc's Market Cap?: Celldex Therapeutics, Inc's Market Cap is $3.1B, based on as-reported figures from SEC (XBRL) filings.
What is Celldex Therapeutics, Inc's Enterprise Value?: Celldex Therapeutics, Inc's Enterprise Value is $2.4B, based on as-reported figures from SEC (XBRL) filings.
What is Celldex Therapeutics, Inc's Price / Sales?: Celldex Therapeutics, Inc's Price / Sales is 19443.5×, based on as-reported figures from SEC (XBRL) filings.
What is Celldex Therapeutics, Inc's EV / Revenue?: Celldex Therapeutics, Inc's EV / Revenue is 14901.8×, based on as-reported figures from SEC (XBRL) filings.
What is Celldex Therapeutics, Inc's EV / EBITDA?: Celldex Therapeutics, Inc's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Celldex Therapeutics, Inc's Revenue (TTM)?: Celldex Therapeutics, Inc's Revenue (TTM) is $158.0K, based on as-reported figures from SEC (XBRL) filings.
What is Celldex Therapeutics, Inc's Net Income (TTM)?: Celldex Therapeutics, Inc's Net Income (TTM) is -$300.5M, based on as-reported figures from SEC (XBRL) filings.
What is Celldex Therapeutics, Inc's EBITDA?: Celldex Therapeutics, Inc's EBITDA is -$322.4M, based on as-reported figures from SEC (XBRL) filings.
What is Celldex Therapeutics, Inc's Diluted EPS (TTM)?: Celldex Therapeutics, Inc's Diluted EPS (TTM) is -3.83, based on as-reported figures from SEC (XBRL) filings.
What is Celldex Therapeutics, Inc's EBITDA Margin?: Celldex Therapeutics, Inc's EBITDA Margin is -204070.9%, based on as-reported figures from SEC (XBRL) filings.